Where Cognex Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have mixed ratings for Cognex (NASDAQ:CGNX) with a recent increase in the average 12-month price target to $49.78. Key analysts have updated their ratings and price targets, reflecting a generally positive outlook. Cognex's financial performance is strong, with notable revenue growth, net margin, ROE, and ROA.
July 23, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cognex has received mixed ratings from analysts, with a recent increase in the average 12-month price target to $49.78. Analysts from firms like Vertical Research, Truist Securities, and HSBC have issued 'Buy' ratings, while Goldman Sachs has a 'Sell' rating. The company's strong financial performance, including revenue growth and profitability, supports a generally positive outlook.
The increase in the average price target and multiple 'Buy' ratings from key analysts indicate a positive short-term impact on Cognex's stock price. The company's strong financial performance further supports this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100